Bismuth-Based Quadruple Therapy as First-Line Treatment for Clarithromycin-Resistant Helicobacter pylori Infection: A Prospective Randomized Comparison of 7- and 14-Day Treatment Regimens
Gut and Liver · 2024
DOI: 10.5009/gnl230453 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Gut and Liver, 2024. Verfasst von Chul-Hyun Lim und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Department of Internal Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, …. Hauptthemen laut MEDLINE: Helicobacter Infections, Helicobacter pylori, Clarithromycin, Anti-Bacterial Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Research Institute of Medical Science, Eunpyeong St. Mary’s Hospital, the Catholic University of Korea, Il-Yang Pharm. Co., Ltd..
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology, Department of Internal Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
ORCID-Profile: Chul-Hyun Lim, Jung-Hwan Oh
Förderung
- Research Institute of Medical Science, Eunpyeong St. Mary’s Hospital, the Catholic University of Korea
- Il-Yang Pharm. Co., Ltd.
Zitieren
APA
Lim, C. H., & Oh, J. H. (2024). Bismuth-Based Quadruple Therapy as First-Line Treatment for Clarithromycin-Resistant Helicobacter pylori Infection: A Prospective Randomized Comparison of 7- and 14-Day Treatment Regimens. Gut and Liver. https://doi.org/10.5009/gnl230453
Vancouver
Lim CH, Oh JH. Bismuth-Based Quadruple Therapy as First-Line Treatment for Clarithromycin-Resistant Helicobacter pylori Infection: A Prospective Randomized Comparison of 7- and 14-Day Treatment Regimens. Gut and Liver. 2024. doi:10.5009/gnl230453
BibTeX
@article{Lim2024,
author = {Lim, Chul-Hyun and Oh, Jung-Hwan},
title = {Bismuth-Based Quadruple Therapy as First-Line Treatment for Clarithromycin-Resistant Helicobacter pylori Infection: A Prospective Randomized Comparison of 7- and 14-Day Treatment Regimens},
journal = {Gut and Liver},
year = {2024},
doi = {10.5009/gnl230453}
}
EUVIMED